Tag Archives: AstraZeneca plc (AZN)

Nektar Therapeutics (NKTR)

Nektar Therapeutics (NKTR) And AstraZeneca plc (AZN) Get Approval of FDA For Movantik

Nektar Therapeutics (NKTR) And AstraZeneca plc (AZN) Get Approval of FDA For Movantik

The U.S. Food and Drug Administration (FDA) has approved Movantik (naloxegol) tablets drugs that are used for the treatment of constipation, Nektar Therapeutics (NASDAQ:NKTR) has said. In the statement, the pharmaceuticals company announced that the drug has successfully gone through the agency’s approval intricacies to attain their approval as a treatment of constipation caused by

AstraZeneca plc (AZN) Acquisition: Hard Nut to Crack for Pfizer Inc. (PFE)

In its efforts to cut elevating tax expenses, Pfizer Inc. (NYSE:PFE) has reinitiated its efforts to takeover the London-based first, AstraZeneca plc (LON:AZN). AstraZeneca plc (LON:AZN) can help in cutting tax rates and offer a new drugs pipeline for Pfizer Inc. (NYSE:PFE). However, the cost of acquiring the London-based firm is rising continuously. According to

Top